/
© 2026 RiffOn. All rights reserved.

Get your free personalized podcast brief

We scan new podcasts and send you the top 5 insights daily.

  1. All-In with Chamath, Jason, Sacks & Friedberg
  2. OpenAI Misses Targets, Codex vs Claude, Elon vs Sam Trial, Big Hyperscaler Beats, Peptide Craze
OpenAI Misses Targets, Codex vs Claude, Elon vs Sam Trial, Big Hyperscaler Beats, Peptide Craze

OpenAI Misses Targets, Codex vs Claude, Elon vs Sam Trial, Big Hyperscaler Beats, Peptide Craze

All-In with Chamath, Jason, Sacks & Friedberg · May 1, 2026

OpenAI's product strength despite missed targets, the trillion-dollar hyperscaler AI capex race, Elon vs. Sam's legal battle, & peptide mania.

The Real Bottleneck in AI's Growth Isn't GPUs, It's the Electrical Grid

The primary constraint for AI giants like OpenAI and Anthropic is not the supply of chips, but the availability of electrical power and grid infrastructure for data centers. This fundamental chokepoint shifts the strategic advantage to hyperscalers who already control massive power and infrastructure assets.

OpenAI Misses Targets, Codex vs Claude, Elon vs Sam Trial, Big Hyperscaler Beats, Peptide Craze thumbnail

OpenAI Misses Targets, Codex vs Claude, Elon vs Sam Trial, Big Hyperscaler Beats, Peptide Craze

All-In with Chamath, Jason, Sacks & Friedberg·15 hours ago

The "Vibe Coding" Hype Is Over; AI Is an Assistant, Not a Developer Replacement

Recent incidents of AI agents causing catastrophic production failures are ending the hype around "vibe coding." The industry consensus is shifting: AI is a powerful productivity multiplier for skilled developers but is not yet capable of managing the complexity, maintenance, and risk of professional software engineering on its own.

OpenAI Misses Targets, Codex vs Claude, Elon vs Sam Trial, Big Hyperscaler Beats, Peptide Craze thumbnail

OpenAI Misses Targets, Codex vs Claude, Elon vs Sam Trial, Big Hyperscaler Beats, Peptide Craze

All-In with Chamath, Jason, Sacks & Friedberg·15 hours ago

All Legacy Software Must Be Rewritten by AI to Eliminate Human-Made Security Flaws

The shift to machine-versus-machine cyber warfare renders all human-written legacy software fundamentally insecure. This will trigger a global imperative to rewrite the world's operational software, not just for efficiency but for survival, with machines doing most of the coding to create impregnable systems.

OpenAI Misses Targets, Codex vs Claude, Elon vs Sam Trial, Big Hyperscaler Beats, Peptide Craze thumbnail

OpenAI Misses Targets, Codex vs Claude, Elon vs Sam Trial, Big Hyperscaler Beats, Peptide Craze

All-In with Chamath, Jason, Sacks & Friedberg·15 hours ago

AI Supremacy Will Depend on Algorithmic Efficiency, Not Just Brute-Force Compute

Breakthroughs like neural network "pruning" can reduce model size by 90% without losing accuracy, offering a 10x reduction in inference costs. This highlights that algorithmic innovation, not just acquiring more hardware, will be a key competitive vector in the AI race, enabling more output with less energy.

OpenAI Misses Targets, Codex vs Claude, Elon vs Sam Trial, Big Hyperscaler Beats, Peptide Craze thumbnail

OpenAI Misses Targets, Codex vs Claude, Elon vs Sam Trial, Big Hyperscaler Beats, Peptide Craze

All-In with Chamath, Jason, Sacks & Friedberg·15 hours ago

OpenAI's Consumer Miss Masks Its Accidental Genius in Enterprise AI

OpenAI's massive compute spending, justified by consumer growth projections it missed, now provides a key advantage in the enterprise and coding AI markets. This positions them ahead of compute-constrained competitors like Anthropic, making Sam Altman's strategy look prescient, albeit for the wrong reasons.

OpenAI Misses Targets, Codex vs Claude, Elon vs Sam Trial, Big Hyperscaler Beats, Peptide Craze thumbnail

OpenAI Misses Targets, Codex vs Claude, Elon vs Sam Trial, Big Hyperscaler Beats, Peptide Craze

All-In with Chamath, Jason, Sacks & Friedberg·15 hours ago

AI Is Now the Primary Driver of the American Economy

No longer a niche sector, AI has become synonymous with U.S. economic growth, reportedly contributing up to 75% of the increase in recent GDP. This makes AI policy a macroeconomic issue, as halting its progress would mean halting the primary engine of the American economy, impacting everything from social programs to national defense.

OpenAI Misses Targets, Codex vs Claude, Elon vs Sam Trial, Big Hyperscaler Beats, Peptide Craze thumbnail

OpenAI Misses Targets, Codex vs Claude, Elon vs Sam Trial, Big Hyperscaler Beats, Peptide Craze

All-In with Chamath, Jason, Sacks & Friedberg·15 hours ago

AI Is Forcing Tech Hyperscalers to Abandon Asset-Light Models for Industrial-Style CapEx

The AI arms race is forcing tech giants like Microsoft and Google into a massive capital expenditure cycle, sacrificing their historically asset-light, high-margin business models. They are transforming into capital-intensive, debt-heavy industrial businesses, which could fundamentally alter their long-term valuation cases.

OpenAI Misses Targets, Codex vs Claude, Elon vs Sam Trial, Big Hyperscaler Beats, Peptide Craze thumbnail

OpenAI Misses Targets, Codex vs Claude, Elon vs Sam Trial, Big Hyperscaler Beats, Peptide Craze

All-In with Chamath, Jason, Sacks & Friedberg·15 hours ago

The U.S. Supreme Court Operates as One of America's Last Highly Functional Institutions

In an era of political decay, the Supreme Court stands out for its rigorous and respected process. First-hand observation reveals a level of institutional sanctity largely absent from other government branches. However, this functionality is fragile and under threat from political movements aiming to alter its structure.

OpenAI Misses Targets, Codex vs Claude, Elon vs Sam Trial, Big Hyperscaler Beats, Peptide Craze thumbnail

OpenAI Misses Targets, Codex vs Claude, Elon vs Sam Trial, Big Hyperscaler Beats, Peptide Craze

All-In with Chamath, Jason, Sacks & Friedberg·15 hours ago

OpenAI President's Diary Becomes a "Smoking Gun" in Elon Musk's Lawsuit

Greg Brockman's personal diary entries, which detailed internal strategies regarding Elon Musk and the company's for-profit pivot, have emerged as critical evidence in the ongoing lawsuit. This serves as a stark warning to executives about the legal risks of journaling sensitive corporate deliberations, a practice dubbed "discovery maxing."

OpenAI Misses Targets, Codex vs Claude, Elon vs Sam Trial, Big Hyperscaler Beats, Peptide Craze thumbnail

OpenAI Misses Targets, Codex vs Claude, Elon vs Sam Trial, Big Hyperscaler Beats, Peptide Craze

All-In with Chamath, Jason, Sacks & Friedberg·15 hours ago

AI Cyber Tools Will Force a Mass Security Upgrade, Not Break the Internet

Advanced AI cyber tools like Anthropic's Mythos don't create new vulnerabilities; they excel at discovering existing, dormant bugs in human-written code. Their proliferation will catalyze a one-time, industry-wide upgrade cycle, ultimately hardening global infrastructure and leading to a more secure equilibrium between AI-powered offense and defense.

OpenAI Misses Targets, Codex vs Claude, Elon vs Sam Trial, Big Hyperscaler Beats, Peptide Craze thumbnail

OpenAI Misses Targets, Codex vs Claude, Elon vs Sam Trial, Big Hyperscaler Beats, Peptide Craze

All-In with Chamath, Jason, Sacks & Friedberg·15 hours ago

Eli Lilly's Peptide Strategy Mirrors a SaaS "Good-Better-Best" Pricing Model

By deeply discounting its older drug, tirzepatide, Eli Lilly is creating a mass-market entry point for weight-loss medication. This allows the company to position its newer, more effective drug, retatrutide, as a premium upgrade product. This tiered portfolio strategy, common in SaaS, maximizes revenue across different customer segments.

OpenAI Misses Targets, Codex vs Claude, Elon vs Sam Trial, Big Hyperscaler Beats, Peptide Craze thumbnail

OpenAI Misses Targets, Codex vs Claude, Elon vs Sam Trial, Big Hyperscaler Beats, Peptide Craze

All-In with Chamath, Jason, Sacks & Friedberg·15 hours ago

Founder Disputes Over Pivots Can Be Averted With an Early "Make Right" Equity Deal

The OpenAI vs. Musk lawsuit suggests a crucial step was missed: when a company fundamentally changes its mission (e.g., nonprofit to for-profit), leadership must proactively offer original funders a revised stake. Executing a "make right" equity deal can prevent the kind of high-stakes litigation OpenAI now faces.

OpenAI Misses Targets, Codex vs Claude, Elon vs Sam Trial, Big Hyperscaler Beats, Peptide Craze thumbnail

OpenAI Misses Targets, Codex vs Claude, Elon vs Sam Trial, Big Hyperscaler Beats, Peptide Craze

All-In with Chamath, Jason, Sacks & Friedberg·15 hours ago